Precursor Cell Lymphoblastic Leukemia-Lymphoma

A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias.

Also Known As:

Acute Lymphoblastic Leukemia; Acute Lymphocytic Leukemia; Lymphoblastic Leukemia; ALL, Childhood; Acute Lymphoid Leukemia; Leukemia, Acute Lymphoblastic; Leukemia, Lymphoblastic, Acute; Leukemia, Lymphoblastic, Acute, L1; Leukemia, Lymphoblastic, Acute, L2; Leukemia, Lymphoblastic, Acute, Philadelphia-Positive; Leukemia, Lymphocytic, Acute; Leukemia, Lymphocytic, Acute, L1; Leukemia, Lymphocytic, Acute, L2; Lymphoblastic Leukemia, Acute; Lymphoblastic Leukemia, Acute, Adult; Lymphoblastic Leukemia, Acute, Childhood; Lymphoblastic Leukemia, Acute, L1; Lymphoblastic Leukemia, Acute, L2; Lymphocytic Leukemia, L1; Lymphocytic Leukemia, L2; Childhood ALL; L1 Lymphocytic Leukemia; L2 Lymphocytic Leukemia; Leukemia, Acute Lymphocytic; Leukemia, Acute Lymphoid; Leukemia, L1 Lymphocytic; Leukemia, L2 Lymphocytic; Lymphoid Leukemia, Acute; Precursor Cell Lymphoblastic Leukemia Lymphoma; Leukemia, Lymphoblastic; Leukemia, Lymphoid, Acute; Lymphoblastic Lymphoma; Lymphocytic Leukemia, Acute; Lymphoma, Lymphoblastic

Neoplasms: 1324753
- Neoplasms by Histologic Type: 2
  - Leukemia: 58722
    - Lymphoid Leukemia: 1718
      - Precursor Cell Lymphoblastic Leukemia-Lymphoma: 20000
Hemic and Lymphatic Diseases: 6
- Hematologic Diseases: 3366
  - Leukemia: 58722
    - Lymphoid Leukemia: 1718
      - Precursor Cell Lymphoblastic Leukemia-Lymphoma: 20000
- Lymphatic Diseases: 92
  - Lymphoproliferative Disorders: 4250
    - Lymphoid Leukemia: 1718
      - Precursor Cell Lymphoblastic Leukemia-Lymphoma: 20000
Immune System Diseases: 4321
- Immunoproliferative Disorders: 29
  - Lymphoproliferative Disorders: 4250
    - Lymphoid Leukemia: 1718
      - Precursor Cell Lymphoblastic Leukemia-Lymphoma: 20000

N J Elzenga Selected Research

N J Elzenga Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure